Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.210
+0.070 (6.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.330
+0.120 (9.92%)
Pre-market: Apr 29, 2026, 5:21 AM EDT
Traws Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 12 | 9 | 32 | 16 | 14 | 53 | |
| Market Cap Growth | 21.12% | -72.02% | 106.05% | 15.90% | -74.63% | -38.16% | |
| Enterprise Value | 8 | 3 | 27 | -10 | -29 | -6 | |
| Last Close Price | 1.21 | 1.13 | 8.88 | 18.64 | 16.14 | 63.75 | |
| PE Ratio | 1.45 | 1.32 | - | - | - | - | |
| PS Ratio | 4.41 | 3.24 | 142.78 | 69.29 | 59.79 | 235.71 | |
| PB Ratio | - | -14.36 | -1.02 | 1.47 | 0.48 | 1.16 | |
| P/TBV Ratio | - | - | - | 1.47 | 0.48 | 1.16 | |
| EV/Sales Ratio | 3.04 | 0.94 | 118.84 | - | - | - | |
| Net Debt / Equity Ratio | 6.07 | 6.07 | 0.68 | -1.95 | -1.37 | -1.19 | |
| Net Debt / EBITDA Ratio | 0.21 | 0.21 | 0.86 | 1.03 | 1.98 | 3.34 | |
| Net Debt / FCF Ratio | 0.21 | 0.21 | 0.72 | 1.16 | 2.38 | 2.83 | |
| Asset Turnover | 0.16 | 0.16 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 0.68 | 0.68 | 2.00 | 2.26 | 4.82 | 9.01 | |
| Current Ratio | 0.72 | 0.72 | 2.16 | 2.46 | 4.89 | 9.07 | |
| Return on Equity (ROE) | - | - | - | -97.22% | -50.96% | -61.81% | |
| Return on Assets (ROA) | -62.80% | -62.80% | -65.35% | -40.89% | -25.87% | -27.32% | |
| Return on Capital Employed (ROCE) | 3379.00% | 3379.00% | -185.50% | -150.80% | -62.70% | -33.40% | |
| Earnings Yield | 55.86% | 101.55% | -516.07% | -121.00% | -140.35% | -30.34% | |
| FCF Yield | -147.96% | -201.39% | -92.33% | -114.60% | -120.59% | -36.58% | |
| Buyback Yield / Dilution | -429.93% | -429.93% | -84.94% | -0.39% | -24.22% | -45.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.